Mixed connective tissue disease with protein-losing enteropathy: discussion of the treatment strategy

J Clin Rheumatol. 2011 Aug;17(5):286-7. doi: 10.1097/RHU.0b013e318227e836.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adult
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / therapeutic use
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use*
  • Comorbidity
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infusions, Intravenous
  • Mixed Connective Tissue Disease / diagnosis
  • Mixed Connective Tissue Disease / drug therapy*
  • Mixed Connective Tissue Disease / epidemiology*
  • Protein-Losing Enteropathies / diagnosis
  • Protein-Losing Enteropathies / drug therapy*
  • Protein-Losing Enteropathies / epidemiology*
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Cyclophosphamide
  • Azathioprine